Pro Medicus Ltd (ASX: PME) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Pro Medicus Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$7.30 billion
P/E Ratio
144.93
Dividend Yield
0.35%
Shares Outstanding
104.43 million
Earnings per share
0.488
Dividend per share
0.26
Year To Date Return
28.57%
Earnings Yield
0.69%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Pro Medicus Ltd (ASX: PME)
Latest News
Share Market News
Here are the top 10 ASX 200 shares today
52-Week Highs
6 ASX 200 shares smashing new 52-week highs on Wednesday
Investing Strategies
How you can pay a premium and still make great returns with high-quality ASX shares
Broker Notes
Top brokers name 3 ASX shares to buy next week
Share Market News
Here are the top 10 ASX 200 shares today
Technology Shares
Goldman Sachs just upgraded this ASX 200 tech share
Share Market News
5 things to watch on the ASX 200 on Friday
Investing Strategies
Golden forgotten metric: The ASX 200 shares that rank highest
Share Market News
3 reasons to buy founder-led ASX shares
How to invest
Here’s how rich you’d be if you invested $20k in these shares 10 years ago
Growth Shares
Why investors shouldn’t rule out buying high p/e ASX shares
Share Market News
5 ASX 200 shares that have doubled in value over 5 years
Frequently Asked Questions
-
Yes, the company historically pays two fully franked dividends a year.
-
Pro Medicus generally pays its shareholder dividends in March and October.
-
Pro Medicus Ltd listed on the ASX on 10 October 2000.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 02 Mar 2023 | $0.1300 | 100.00% | Interim | 24 Mar 2023 |
| 08 Sep 2022 | $0.1200 | 100.00% | Final | 30 Sep 2022 |
| 03 Mar 2022 | $0.1000 | 100.00% | Interim | 25 Mar 2022 |
| 09 Sep 2021 | $0.0800 | 100.00% | Final | 01 Oct 2021 |
| 04 Mar 2021 | $0.0700 | 100.00% | Interim | 19 Mar 2021 |
| 10 Sep 2020 | $0.0600 | 100.00% | Final | 02 Oct 2020 |
| 05 Mar 2020 | $0.0600 | 100.00% | Interim | 20 Mar 2020 |
| 12 Sep 2019 | $0.0450 | 100.00% | Final | 04 Oct 2019 |
| 12 Mar 2019 | $0.0250 | 100.00% | Special Cash | 17 May 2019 |
| 07 Mar 2019 | $0.0350 | 100.00% | Interim | 22 Mar 2019 |
| 06 Sep 2018 | $0.0350 | 100.00% | Final | 27 Sep 2018 |
| 08 Mar 2018 | $0.0250 | 100.00% | Interim | 23 Mar 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 28 Sep 2017 |
| 08 Sep 2016 | $0.0150 | 0.00% | Final | 29 Sep 2016 |
| 10 Mar 2016 | $0.0150 | 0.00% | Interim | 24 Mar 2016 |
| 15 Mar 2006 | $0.0050 | 100.00% | Special | 05 Apr 2006 |
| 15 Mar 2006 | $0.0200 | 100.00% | Interim | 05 Apr 2006 |
| 14 Sep 2005 | $0.0050 | 100.00% | Special Cash | 04 Oct 2005 |
| 14 Sep 2005 | $0.0275 | 100.00% | Final | 04 Oct 2005 |
| 16 Mar 2004 | $0.0125 | 100.00% | Interim | 05 Apr 2004 |
PME ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Pro Medicus Ltd
Pro Medicus Ltd (ASX: PME) is a provider of medical imaging technology globally. The company is recognised as a leading supplier of radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions for medical practices and hospitals.
Pro Medicus's RIS technology products also include medical accounting, clinical reporting, appointments/scheduling, and marketing/management applications. The company's services to the imaging sector cover workflow mapping and optimisation, network design and implementation, hardware sourcing and configuration, and staff and management training.
Pro Medicus has offices in Australia, Germany, and the US with its products adopted by many top-tier hospitals and health facilities, particularly in the US market.
PME Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 Aug 2023 | $70.92 | $-0.58 | -0.81% | 132,299 | $70.54 | $71.03 | $70.20 |
| 08 Aug 2023 | $71.50 | $0.47 | 0.66% | 126,870 | $70.86 | $71.50 | $70.72 |
| 07 Aug 2023 | $71.03 | $0.79 | 1.12% | 118,513 | $70.70 | $71.17 | $70.30 |
| 04 Aug 2023 | $70.24 | $0.34 | 0.49% | 152,674 | $69.65 | $70.24 | $69.12 |
| 03 Aug 2023 | $69.90 | $-1.18 | -1.66% | 135,461 | $69.60 | $70.15 | $68.50 |
| 02 Aug 2023 | $71.08 | $2.06 | 2.98% | 225,618 | $70.35 | $71.60 | $69.92 |
| 01 Aug 2023 | $69.02 | $0.23 | 0.33% | 152,792 | $68.61 | $69.73 | $68.35 |
| 31 Jul 2023 | $68.79 | $-0.49 | -0.71% | 257,739 | $69.96 | $70.55 | $68.37 |
| 28 Jul 2023 | $69.28 | $1.34 | 1.97% | 207,410 | $68.88 | $69.87 | $67.69 |
| 27 Jul 2023 | $67.94 | $0.99 | 1.48% | 148,881 | $67.75 | $68.80 | $67.23 |
| 26 Jul 2023 | $66.95 | $0.06 | 0.09% | 90,237 | $67.22 | $67.69 | $66.50 |
| 25 Jul 2023 | $66.89 | $-0.12 | -0.18% | 91,405 | $67.50 | $67.90 | $65.89 |
| 24 Jul 2023 | $67.01 | $0.51 | 0.77% | 127,282 | $66.51 | $67.36 | $66.01 |
| 21 Jul 2023 | $66.50 | $0.72 | 1.09% | 152,801 | $65.64 | $67.07 | $65.16 |
| 20 Jul 2023 | $65.78 | $0.03 | 0.05% | 57,779 | $65.75 | $66.50 | $65.48 |
| 19 Jul 2023 | $65.75 | $-0.08 | -0.12% | 68,591 | $65.96 | $66.15 | $65.56 |
| 18 Jul 2023 | $65.83 | $-0.09 | -0.14% | 56,723 | $65.94 | $66.45 | $65.33 |
| 17 Jul 2023 | $65.92 | $0.43 | 0.66% | 262,619 | $66.06 | $66.50 | $65.48 |
| 14 Jul 2023 | $65.49 | $0.59 | 0.91% | 111,796 | $65.00 | $65.68 | $64.00 |
| 13 Jul 2023 | $64.90 | $1.06 | 1.66% | 108,154 | $64.84 | $65.14 | $64.64 |
| 12 Jul 2023 | $63.84 | $0.11 | 0.17% | 103,417 | $64.15 | $64.75 | $63.68 |
| 11 Jul 2023 | $63.73 | $1.28 | 2.05% | 99,489 | $63.26 | $63.73 | $62.19 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Mar 2023 | Sam Hupert | Sell | 1 | $62,220,000 |
On-market trade.
|
| 15 Mar 2023 | Anthony Hall | Sell | 1 | $62,220,000 |
On-market trade.
|
| 13 Mar 2023 | Peter Kempen | Sell | 3 | $221,153 |
On-market trade.
|
| 10 Mar 2023 | Peter Kempen | Sell | 10 | $611,922 |
On-market trade.
|
| 09 Mar 2023 | Peter Kempen | Sell | 11 | $715,200 |
On-market trade.
|
| 08 Mar 2023 | Peter Kempen | Sell | 15 | $932,710 |
On-market trade.
|
| 07 Mar 2023 | Peter Kempen | Sell | 10 | $615,691 |
On-market trade.
|
| 22 Aug 2022 | Alice Williams | Buy | 250 | $13,440 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Sam Aaron Hupert | Chief Executive OfficerManaging Director | Oct 2007 |
Dr Hupert commenced General Practice in 1980. Sam served as CEO from the time he co-founded the company until October 2007 at which time he stepped down to become an executive director. Sam resumed full time CEO activities in October of 2010.
|
| Mr Anthony Barry Hall | Executive DirectorTechnology Director | Jan 1983 |
Mr Hall has been principal architect and developer of the core software systems. His current focus is the transition to and development of the Company's next generation RIS systems.
|
| Mr Peter Terence Kempen | Non-Executive ChairmanNon-Executive Director | Mar 2008 |
Mr Kempen is Chairman of Australasian Leukemia and Lymphoma Group. He is also a Trustee of the Barr Family Foundation and a member of the Board of St Hilda's College Ltd, University of Melbourne. Peter has previously been Chairman of Patties Food Limited, Chairman of Danks Holdings Limited, Chairman of Ivanhoe Grammar School and Managing Partner of Ernst & Young Corporate Finance Australia.
|
| Ms Alice Joan Morrice Williams | Non-Executive Director | Sep 2021 |
Ms Williams holds other board positions with Tobacco Free Portfolios, is a non-executive Director and member of the Audit & Risk Committee and Due Diligence Committee of Mercer Investments (Australia) Ltd and is on a Project Advisory Council of the Florey Institute of Neuroscience.
|
| Ms Deena Robyn Shiff | Non-Executive Director | Aug 2020 |
Ms Shiff has served as a Group Managing Director at Telstra, where she led the Wholesale Division Group, established and led Telstra Business and founded Telstra's corporate venture capital arm, Telstra Ventures. Deena has also held various in house regulatory and legal positions and has been a Partner of the law firm Mallesons Stephen Jacques.
|
| Mr Anthony James Glenning | Non-Executive Director | May 2016 |
Mr is the fund manager of Skalata Ventures. Anthony has previously been Chairman of Cyrise Pty Ltd, an accelerator for earlystage cyber security start-ups and Investment Director of Starfish Ventures and was the founder and previously the CEO of Tonic Systems and a founding Non-Executive Director of Cameron Systems.
|
| Dr Leigh Bernard Farrell | Non-Executive Director | Sep 2017 |
Dr Farrell is the Head of the Health Security Division of DMTC Ltd, Managing Director of AdNED Pty Ltd, nonexecutive director of both Ena Respiratory Pty Ltd and Alexia Oncology Pty Ltd, a member of the Walter and Eliza Hall Institute of Medical Research Board Commercialisation Committee and a member of the Independent Advisory Council of Medicines Australia. Leigh was previously Senior Vice President, Commercial of Certara USA, Inc.
|
| Ms Danny English | Company Secretary | Mar 2023 |
-
|
| Clayton Hatch | Chief Financial Officer |
-
|
|
| Danny English | Company Secretary |
-
|
|
| Danny Tauber | General Manager - Pro Medicus Limited |
-
|
|
| Brad Levin | General Manager - Visage Imaging Inc. |
-
|
|
| Sean Lambright | Global Head of Sales - Visage Imaging Inc. |
-
|
|
| Malte Westerhoff | Managing Director - Visage Imaging GmbH |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Dr S Hupert (multiple shareholdings) | 27,137,660 | 26.02% |
| Mr A Hall (multiple shareholdings) | 27,109,000 | 25.99% |
| HSBC Custody Nominees (Australia) Limited | 13,748,758 | 13.18% |
| Citicorp Nominees Pty Ltd | 6,116,390 | 5.86% |
| J P Morgan Nominees Australia Limited | 5,408,651 | 5.19% |
| BNP Paribas Noms Pty Ltd | 1,648,997 | 1.58% |
| National Nominees Limited | 1,178,519 | 1.13% |
| Citicorp Nominees (Colonial First State) | 776,654 | 0.74% |
| Mr Peter Terence Kempen & Mrs Elaine Margaret Kempen | 679,082 | 0.65% |
| Mr Bram Vander Jagt & Mrs Maaike Vander Jagt | 520,000 | 0.50% |
| Grain Exporters (Australia) Pty Ltd | 495,000 | 0.47% |
| Mr Michael Wu | 430,244 | 0.41% |
| Milton Corporation Limited | 350,000 | 0.34% |
| Mr Danny Tauber | 288,053 | 0.28% |
| Mr Stephen Geoffrey Wilson & Ms Denise Adele Prandi | 285,037 | 0.27% |
| Mr Roderick Lyle (multiple shareholdings) | 284,000 | 0.27% |
| Mr Colin Gregory Organ | 271,000 | 0.26% |
| Ubs Nominees Pty Ltd | 255,353 | 0.24% |
| Mr John Charles Plummer | 250,000 | 0.24% |
| Mr Kenneth John Vander Jagt & Mrs Tanya Vander Jagt | 238,159 | 0.23% |